Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) a Buy, Sell, or Hold?
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$8.93 USD
-$0.1 (-1.11%)
- Volume
- 63.85K
- Average Volume
- 504.28K
- Market Capitalization
- $111.94M
- P/E Ratio
- -1.35
- Dividend Yield
- 0.00%
- Price Target
- $38.50
- Year High
- $20.56
- Year Low
- $7.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.92
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
40
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
20
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 158.01K
CRBP Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CRBP Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Kung Winston | director | 2026-06-10 | S-Sale | 7.9137 | 2026-06-11 |
| Altmeyer Anne | director | 2026-06-10 | S-Sale | 7.9137 | 2026-06-11 |
| Jenkins John Kenneth | director | 2026-06-10 | S-Sale | 7.9137 | 2026-06-11 |
| Saxena Nishant C | officer: Chief Business Officer | 2026-06-03 | P-Purchase | 7.58 | 2026-06-03 |
| Saxena Nishant C | officer: Chief Business Officer | 2026-06-02 | P-Purchase | 7.333 | 2026-06-03 |
| Saxena Nishant C | officer: Chief Business Officer | 2026-05-21 | A-Award | 11.51 | 2026-05-22 |
| Saxena Nishant C | officer: Chief Business Officer | 2026-05-21 | A-Award | 0 | 2026-05-22 |
| Saxena Nishant C | officer: Chief Business Officer | 2026-05-21 | 0 | 2026-05-22 | |
| Kung Winston | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Kung Winston | director | 2026-05-19 | A-Award | 9.15 | 2026-05-21 |
| Jacques Rachelle Suzanne | director | 2026-05-19 | A-Award | 9.15 | 2026-05-21 |
| Jacques Rachelle Suzanne | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Jenkins John Kenneth | director | 2026-05-19 | A-Award | 9.15 | 2026-05-21 |
| Jenkins John Kenneth | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Altmeyer Anne | director | 2026-05-19 | A-Award | 9.15 | 2026-05-21 |
| Altmeyer Anne | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Ben Yong | director | 2026-05-19 | A-Award | 9.15 | 2026-05-21 |
| Ben Yong | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Pfeiffenberger Brent | director | 2026-05-19 | A-Award | 9.15 | 2026-05-21 |
| Pfeiffenberger Brent | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Pfeiffenberger Brent | 2026-05-13 | 0 | 2026-05-21 | ||
| Smethurst Dominic | officer: Chief Medical Officer | 2026-03-02 | S-Sale | 8.2994 | 2026-03-04 |
| Hodgson Ian | officer: Chief Operating Officer | 2026-02-17 | S-Sale | 7.383 | 2026-02-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2026-02-13 | S-Sale | 7.783 | 2026-02-18 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2026-02-13 | S-Sale | 7.7826 | 2026-02-18 |
| Smethurst Dominic | officer: Chief Medical Officer | 2026-02-03 | S-Sale | 8.0898 | 2026-02-04 |
| Hodgson Ian | officer: Chief Operating Officer | 2026-02-03 | S-Sale | 8.0899 | 2026-02-04 |
| Smethurst Dominic | officer: Chief Medical Officer | 2026-01-14 | A-Award | 0 | 2026-01-16 |
| Smethurst Dominic | officer: Chief Medical Officer | 2026-01-14 | A-Award | 8.26 | 2026-01-16 |
| Moran Sean F. | officer: Chief Financial Officer | 2026-01-14 | A-Award | 0 | 2026-01-16 |
| Moran Sean F. | officer: Chief Financial Officer | 2026-01-14 | A-Award | 8.26 | 2026-01-16 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2026-01-14 | A-Award | 0 | 2026-01-16 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2026-01-14 | A-Award | 8.26 | 2026-01-16 |
| Hodgson Ian | officer: Chief Operating Officer | 2026-01-14 | A-Award | 8.26 | 2026-01-16 |
| Hodgson Ian | officer: Chief Operating Officer | 2026-01-14 | A-Award | 0 | 2026-01-16 |
| Cormorant Asset Management, LP | 10 percent owner | 2025-12-11 | S-Sale | 11.456 | 2025-12-15 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2025-10-24 | M-Exempt | 4.26 | 2025-10-27 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2025-10-27 | M-Exempt | 4.26 | 2025-10-27 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2025-10-27 | S-Sale | 17.14 | 2025-10-27 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2025-10-24 | S-Sale | 17.01 | 2025-10-27 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2025-10-24 | M-Exempt | 4.26 | 2025-10-27 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2025-10-27 | M-Exempt | 4.26 | 2025-10-27 |
| Moran Sean F. | officer: Chief Financial Officer | 2025-10-24 | M-Exempt | 4.26 | 2025-10-27 |
| Moran Sean F. | officer: Chief Financial Officer | 2025-10-24 | S-Sale | 17.02 | 2025-10-27 |
| Moran Sean F. | officer: Chief Financial Officer | 2025-10-24 | M-Exempt | 4.26 | 2025-10-27 |
| Altmeyer Anne | director | 2025-10-20 | M-Exempt | 4.8 | 2025-10-21 |
| Altmeyer Anne | director | 2025-10-20 | S-Sale | 20.5 | 2025-10-21 |
| Altmeyer Anne | director | 2025-10-20 | M-Exempt | 4.8 | 2025-10-21 |
| Kung Winston | director | 2025-05-30 | A-Award | 7.42 | 2025-06-02 |
| Kung Winston | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |
| Jenkins John Kenneth | director | 2025-05-30 | A-Award | 7.42 | 2025-06-02 |
| Jenkins John Kenneth | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |
| Jenkins John Kenneth | director | 2025-05-30 | S-Sale | 7.3537 | 2025-06-02 |
| Ben Yong | director | 2025-05-30 | A-Award | 7.42 | 2025-06-02 |
| Ben Yong | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |
| Altmeyer Anne | director | 2025-05-30 | A-Award | 7.42 | 2025-06-02 |
| Altmeyer Anne | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |
| Altmeyer Anne | director | 2025-05-30 | S-Sale | 7.2526 | 2025-06-02 |
| HOLMER ALAN F | director | 2025-05-30 | A-Award | 7.42 | 2025-06-02 |
| HOLMER ALAN F | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |
| Jacques Rachelle Suzanne | director | 2025-05-30 | A-Award | 7.42 | 2025-06-02 |
| Jacques Rachelle Suzanne | director | 2025-05-30 | A-Award | 0 | 2025-06-02 |
| Hodgson Ian | officer: Chief Operating Officer | 2025-03-13 | 0 | 2025-03-18 | |
| Hodgson Ian | officer: Chief Operating Officer | 2025-03-13 | 0 | 2025-03-18 | |
| Hodgson Ian | officer: Chief Operating Officer | 2025-03-13 | 9.79 | 2025-03-18 | |
| Hodgson Ian | officer: Chief Operating Officer | 2025-03-13 | 23.1 | 2025-03-18 | |
| Hodgson Ian | officer: Chief Operating Officer | 2025-03-13 | 3.81 | 2025-03-18 | |
| Hodgson Ian | officer: Chief Operating Officer | 2025-03-13 | 4.26 | 2025-03-18 | |
| Smethurst Dominic | officer: Chief Medical Officer | 2025-03-06 | S-Sale | 6.7777 | 2025-03-07 |
| Moran Sean F. | officer: Chief Financial Officer | 2025-02-14 | S-Sale | 8.7559 | 2025-02-18 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2025-02-14 | S-Sale | 8.7559 | 2025-02-18 |
| Smethurst Dominic | officer: Chief Medical Officer | 2025-01-31 | A-Award | 9.79 | 2025-02-04 |
| Smethurst Dominic | officer: Chief Medical Officer | 2025-01-31 | A-Award | 0 | 2025-02-04 |
| Moran Sean F. | officer: Chief Financial Officer | 2025-01-31 | A-Award | 9.79 | 2025-02-04 |
| Moran Sean F. | officer: Chief Financial Officer | 2025-01-31 | A-Award | 0 | 2025-02-04 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2025-01-31 | A-Award | 9.79 | 2025-02-04 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2025-01-31 | A-Award | 0 | 2025-02-04 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-09-20 | P-Purchase | 22.228 | 2024-09-24 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-09-20 | P-Purchase | 21.474 | 2024-09-24 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-09-20 | P-Purchase | 20.418 | 2024-09-24 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-09-20 | P-Purchase | 19.611 | 2024-09-24 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-09-20 | P-Purchase | 18.36 | 2024-09-24 |
| Cormorant Asset Management, LP | 10 percent owner | 2024-09-20 | P-Purchase | 17.475 | 2024-09-24 |
| Kung Winston | director | 2024-08-16 | A-Award | 53.52 | 2024-08-20 |
| Kung Winston | director | 2024-08-16 | A-Award | 0 | 2024-08-20 |
| Kung Winston | 2024-08-16 | 0 | 2024-08-20 | ||
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-14 | M-Exempt | 4.26 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-17 | M-Exempt | 14.1 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-18 | M-Exempt | 30 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-14 | M-Exempt | 30 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-17 | S-Sale | 46.774 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-14 | S-Sale | 49.8738 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-18 | S-Sale | 42.1242 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-14 | M-Exempt | 4.26 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-17 | M-Exempt | 14.1 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-14 | M-Exempt | 30 | 2024-06-18 |
| Moran Sean F. | officer: Chief Financial Officer | 2024-06-18 | M-Exempt | 30 | 2024-06-18 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2024-06-14 | M-Exempt | 14.1 | 2024-06-18 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2024-06-14 | M-Exempt | 4.26 | 2024-06-18 |
| Cohen Yuval | director, officer: Chief Executive Officer | 2024-06-18 | M-Exempt | 30 | 2024-06-18 |